CARDIOVASCULAR

Northwestern Medicine Bluhm Cardiovascular Institute holds an enduring commitment to improving the health of our patients through expert patient care, advanced education and breakthrough science. By placing an emphasis on listening to our patients’ needs, Bluhm Cardiovascular Institute has become a destination for those requiring highly specialized cardiovascular care, including both initial diagnoses and second opinions.

Clinical trials in CARDIOVASCULAR

Currently over 75 percent of Bluhm Cardiovascular Institute faculty are involved in clinical research. Our clinical research portfolio includes over 100 ongoing clinical trials, with 65 actively enrolling. To view all clinical trials, visit Bluhm Cardiovascular Institute -- Clinical Trials Unit.

REPAIR MR

CARDIO-TTRansform
This clinical trial is enrolling patients with severe primary MR who are at moderate surgical risk and have been determined to be suitable candidates for mitral valve surgery. Eligible participants will be randomized 1:1 to receive the MitraClip device or traditional mitral valve repair surgery. The primary endpoint incudes all-cause mortality, stroke, cardiac hospitalization, or acute kidney injury requiring renal replacement therapy at 2 years.
National Co-Principal Investigator:
Patrick M. McCarthy, MD
Principal Investigator: 
Charles J. Davidson, MD
This phase 3 global, double-blind, randomized, placebo‑controlled study is enrolling patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) to determine if AKCEA-TTR-LRx, an investigational antisense drug, is safe and effective at slowing the progression of cardiomyopathy and improving quality of life for people living with ATTR-CM. The primary endpoint is a composite of CV mortality and recurrent CV clinical events including cardiac hospitalizations at Week 120.
Principal Investigator:
Sanjiv J. Shah, MD

Updates from Northwestern medicine CARDIOVASCULAR

CONGRATULATIONS

Sanjiv J. Shah, MD, director of the Institute for Augmented Intelligence in Medicine and professor of Medicine in the Department of Cardiology, was awarded $16.7M over five years to help fund his work with the HeartShare Data Translation Center. This program uses machine learning and multi-omics to improve classification and phenotyping of HFpEF, with the goal of developing new therapies. 

Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number U54HL160273. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Follow Northwestern Medicine CARDIOVASCULAR

CME at northwestern medicine cardiovascular

November 17, December 8, January 12, January 26, February 9 and February 23
Location: Virtual
​
A Heart Team is now a standard treatment approach for treating complex cardiovascular patients. This virtual educational series will provide expert lectures and case presentations geared toward health care professionals who may be part of a Heart Team. Included will be the latest innovations as well as standard treatments, including transcatheter valvular heart therapies and coronary revascularization strategies.​
December 10 - 11, 2021
Location: Virtual 
​
This symposium is respected as a top tier regional heart failure meeting and is endorsed by the Heart Failure Society of America (HFSA). The symposium assembles leading cardiologists, cardiac surgeons, nurses and psychologists with expertise in heart failure and cardiac surgery to provide updates on the very latest clinical, scientific, genetic, behavioral and technological advances for managing patients with heart failure.
December 9 - 11, 2021
Location: Chicago, Illinois
​
Bringing together national experts from various fields of vascular care, this educational event provides a comprehensive analysis of the current management of vascular disease. The target audience includes healthcare professionals who detect, diagnose, manage and treat vascular diseases, including but not limited to aneurysms, stroke prevention, peripheral vascular disease, venous disease and blood flow issues.
To view all CME opportunities offered by Bluhm Cardiovascular Institute, visit cvconferences.com.
 

find a cardiovascular physician

Refer a Patient Using the NM Cardiovascular, MD Referral App
NM Cardiovascular MD Referral makes it easy to discover, contact and refer patients to any Bluhm Cardiovascular Institute physician.